Skip to main content

Radiopharm Theranostics Ltd

RADX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001949257

No open-market purchases or sales by Radiopharm Theranostics Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.

Other share classesRDPTF

Q3 2025 vs. Q2 2025

How the institutions holding Radiopharm Theranostics Ltd changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of RADX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders54−1
Shares339.7K312.5K−27.2K (−8.0%)
Value$1.58M$1.73M+$148.2K (+9.4%)

New holders (0)

Institutions that held Radiopharm Theranostics Ltd at the end of Q3 2025 but not at the end of Q2 2025.

None.

Sold out (1)

Institutions that held Radiopharm Theranostics Ltd at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of RADX in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Affinity Asset Advisors, LLC35,635$166.1K